Literature DB >> 8071125

Antimicrobial activities of indolocarbazole and bis-indole protein kinase C inhibitors.

M Sancelme1, S Fabre, M Prudhomme.   

Abstract

The antimicrobial activities of twenty-two substances structurally related to staurosporine, aglycone in the indolocarbazole and bis-indole series were examined against Streptomyces chartreusis and Streptomyces griseus, Bacillus cereus, Escherichia coli, Candida albicans and Botrytis cinerea. Inhibition of sporulation was examined also on the two species of Streptomyces. Unlike literature reports for efficient protein kinase inhibitors, staurosporine and K-252a, no evident correlation could be found either between protein kinase inhibitory potencies and inhibition of sporulation of the Streptomyces species, or protein kinase inhibitory potencies and growth of all microorganisms tested. A weak activity against C. albicans was observed for the chloro-indolocarbazole compounds as already reported for structurally related substances from the cyanobacterium Tolypothrix tjipanasensis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071125     DOI: 10.7164/antibiotics.47.792

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Targeted metagenomics: finding rare tryptophan dimer natural products in the environment.

Authors:  Fang-Yuan Chang; Melinda A Ternei; Paula Y Calle; Sean F Brady
Journal:  J Am Chem Soc       Date:  2015-05-04       Impact factor: 15.419

2.  Combinatorial biosynthesis of antitumor indolocarbazole compounds.

Authors:  César Sánchez; Lili Zhu; Alfredo F Braña; Aaroa P Salas; Jürgen Rohr; Carmen Méndez; José A Salas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

3.  A Co-Culturing Approach Enables Discovery and Biosynthesis of a Bioactive Indole Alkaloid Metabolite.

Authors:  Fleurdeliz Maglangit; Qing Fang; Kwaku Kyeremeh; Jeremy M Sternberg; Rainer Ebel; Hai Deng
Journal:  Molecules       Date:  2020-01-08       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.